7Baggers
 Gossamer Bio stock outlook positive as seralutinib trial nears completion By Investing.com  Investing.com South Africa Fri, 14 Nov 2025 05:17:12 GMT
 Gossamer Bio price target raised to $12 from $9 at Oppenheimer  TipRanks Mon, 10 Nov 2025 15:35:40 GMT
 gossamer bio reports q3 2025 results and updates  MSN Sat, 08 Nov 2025 11:08:14 GMT
 Gossamer Bio to Participate in Upcoming Investor Conferences  Yahoo Finance Fri, 07 Nov 2025 08:00:00 GMT
 gossamer bio earnings missed by $0.02, revenue topped estimates  Investing.com Australia Thu, 06 Nov 2025 18:56:24 GMT
 gossamer bio reports q3 2025 results and updates  TipRanks Thu, 06 Nov 2025 05:43:58 GMT
 gossamer bio: q3 earnings snapshot  Chron Thu, 06 Nov 2025 00:33:47 GMT
 Gossamer Bio’s Losses Grow, But Wall Street Stays Optimistic  Finimize Thu, 06 Nov 2025 00:19:17 GMT
 Gossamer Bio Inc (GOSS) Q3 2025 Earnings: Revenue Surges to $13.  GuruFocus Thu, 06 Nov 2025 00:15:56 GMT
 Gossamer Bio, Inc. SEC 10-Q Report  TradingView Wed, 05 Nov 2025 22:29:25 GMT
 gossamer bio's q3 net loss widens to $48.2 mln  MarketScreener Wed, 05 Nov 2025 21:27:58 GMT
 brief-gossamer bio q3 eps usd -0.21  TradingView Wed, 05 Nov 2025 21:01:47 GMT
 gossamer bio reports q3 eps (21c), consensus (20c)  TipRanks Wed, 05 Nov 2025 21:00:00 GMT
 Gossamer Bio (GOSS) Reports Q3 Loss, Tops Revenue Estimates  Yahoo Finance Wed, 05 Nov 2025 08:00:00 GMT
 Gossamer Bio: Q3 Earnings Snapshot  San Antonio Express-News Wed, 05 Nov 2025 08:00:00 GMT
 Gossamer Bio earnings missed by $0.02, revenue topped estimates  Investing.com Wed, 05 Nov 2025 08:00:00 GMT
 Gossamer Bio Reports Q3 2025 Results and Updates  TipRanks Wed, 05 Nov 2025 08:00:00 GMT

Gossamer Bio, Inc
(NASDAQ:GOSS) 

GOSS stock logo

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. It is developing GB001, an oral antagonist of prostaglandin D2 receptor...

Founded: 2015
Full Time Employees: 171
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends